ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain
Public ClinicalTrials.gov record NCT07568015. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain: A Multi-Center, Randomized, Controlled Trial (RENEU)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this clinical trial is to evaluate the safety and analgesic performance of the ReneuRx™ device in subjects with moderate to severe chronic lateral hip pain compared to subjects receiving treatment with corticosteroid injection in adults aged 22-80 years. Participants will attend study visits and complete quality of life questionnaires. Participants will be followed for approximately 6-12 months after the study procedure.
Study identification
- NCT ID
- NCT07568015
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 26, 2026
- Primary completion
- Oct 31, 2027
- Completion
- Oct 31, 2029
- Last update posted
- Aug 3, 2026
2026 – 2029
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Healthcare Outcomes Performance Company | Sun City | Arizona | 85023 | Not yet recruiting |
| Emory Orthopedics and Spine Center | Johns Creek | Georgia | 30097 | Not yet recruiting |
| Ochsner Health Center | New Orleans | Louisiana | 70121 | Not yet recruiting |
| Skylight Health Research | Burlington | Massachusetts | 01803 | Not yet recruiting |
| Mass General Brigham | Chestnut Hill | Massachusetts | 02467 | Not yet recruiting |
| Virtua Health | Sewell | New Jersey | 08080 | Not yet recruiting |
| The Orthopaedic Center | Tulsa | Oklahoma | 74137 | Not yet recruiting |
| Rothman Orthopaedics | King of Prussia | Pennsylvania | 19406 | Not yet recruiting |
| Pain Diagnostics & Interventional Care | Sewickley | Pennsylvania | 15143 | Not yet recruiting |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | Not yet recruiting |
| All-American Orthopedic & Sports | Houston | Texas | 77058 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Greater Trochanteric Pain Syndrome trials
Other public records listing Greater Trochanteric Pain Syndrome. Sorted by last update posted; newest first. Not a recommendation.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07568015, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 3, 2026 · Synced Aug 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07568015 live on ClinicalTrials.gov.